We are a regional biopharma company specializing in the commercialization of innovative biopharmaceutical products targeting severe and rare diseases in South East Europe.
Headquartered in Nicosia, Genesis Pharma (Cyprus) Ltd was founded with the mission to ensure that patients suffering from severe and rare diseases, have direct access to innovative branded medicines. Guided by this same mission, the company is operating in the region through its affiliate in Athens Greece and its local subsidiaries in Bulgaria, Romania, Croatia, Slovenia, Serbia, and North Macedonia.
The company has established long-term alliances with leading global biopharma companies and is responsible for a unique portfolio which includes innovative biopharmaceuticals that tackle severe and rare diseases. Its novel branded pharmaceutical products cover the therapeutic areas of Haematology, Oncology, Central Nervous System, Nephrology, Gastroenterology, Rheumatology-Dermatology as well as Rare Genetic Inherited diseases.
Genesis Pharma (Cyprus) Ltd is affiliated (sister company) to GENESIS Pharma SA in Athens, Greece.